Companies reset M&A, investment strategies to navigate COVID-19 headwinds

February 22, 2021

Why RNA technology leads the immunity race against COVID-19

The quest to build immunity against the ravaging COVID-19 has been led by six vaccine developers.

As companies continue to navigate the current COVID-19 pandemic environment and its unprecedented disruption, business executives are emboldened to reset their mergers and acquisitions (M&A) and investment strategies to secure growth for their businesses in the post-pandemic world, according to

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```